Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations.

Source:http://linkedlifedata.com/resource/pubmed/id/17311862

Download in:

View as

General Info

PMID
17311862